News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Ben Westphalen: New biomarkers in non-colorectal dMMR tumors highlighted in NCI MATCH
Photo of Benedikt Westphalen taken from LinkedIn
Dec 16, 2024, 08:08

Ben Westphalen: New biomarkers in non-colorectal dMMR tumors highlighted in NCI MATCH

Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, shared some insights from an article by Jonathan D. Schoenfeld et al. on X:

“In Clinical Cancer Research – new data from NCI MATCH:

Arm Z1D highlights new biomarkers in non-colorectal dMMR tumors: NGS-based MSI and immune infiltration predict response to PD-1 blockade with nivolumab.”

Next generation sequencing-based MSI scoring predict benefit in mismatch repair deficient tumors treated with nivolumab: follow-up on NCI-MATCH arm Z1D

Authors: Jonathan D. Schoenfeld, Nilofer S. Azad, Jacob Gross, Li Chen, Michael J. Overman, Katrina Kao, Latifa F. Jackson, Donna Brunnquell, Xiangning Bu, Christina Coppola, Ping Guan, Jennifer Lee, David Sims, Rebecca Fuchs, Jason L. Weirather, Kathleen L. Pfaff, Lauren Gunasti, Srin Ranasinghe, Stanley R. Hamilton, Victoria Wang, Peter J. O’Dwyer, Catherine J. Wu, Scott J. Rodig, David R. Patton, Lyndsay Harris

Ben Westphalen: New biomarkers in non-colorectal dMMR tumors highlighted in NCI MATCH

Ben Westphalen biomarkers Cancer research Catherine J. Wu CCR AACR Christina Coppola David R. Patton David Sims dMMR tumors Donna Brunnquell genetic data Immune Infiltration Jacob Gross Jason L. Weirather Jennifer Lee Jonathan D. Schoenfeld Kathleen L Pfaff Katrina Kao Latifa F. Jackson Lauren Gunasti Li Chen Lyndsay Harris Michael J. Overman NCI MATCH NGS-based MSI Nilofer S. Azad nivolumab non-colorectal tumors OncoDaily Oncology oncology research PD-1 blockade Peter J. O’Dwyer Ping Guan Precision Medicine Rebecca Fuchs Scott J Rodig Srin Ranasinghe Stanley R. Hamilton Victoria Wang Xiangning Bu
Special Coverage
OncoDaily Pulse
Aug 21, 2025, 10:23
Archana Ajmera: Meet the Experts of VIRO 2025
OncoDaily Pulse
Aug 21, 2025, 10:08
Yüksel Ürün: Meet the Experts of VIRO 2025
Voices
Aug 21, 2025, 09:46
Pratiti Bandopadhayay: Urgent Need to Sustain Funding for Pediatric Brain Tumor Trials
Voices
Aug 21, 2025, 09:30
Jana Ellegast: Inflammatory Signaling in the Pathogenesis of AML
Insight
Aug 21, 2025, 09:02
Humaid Al-Shamsi: Outcomes of HSCT from Matched Related Donors in Pediatric Patients
Celebrities
Aug 21, 2025, 08:40
World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer
Insight
Aug 21, 2025, 08:17
Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark
Science
Aug 21, 2025, 06:29
Moazzam Shahzad: The Impact of MRD Status after Matched Donor alloHCT in AML
Insight
Aug 21, 2025, 00:36
Tom Powles: IMVIGOR011 Trial Brings ctDNA-Guided Adjuvant Immunotherapy to Bladder Cancer
Voices
Aug 21, 2025, 00:00
Kristina Lindemann: Advancing Gynecological Cancer Trials with ENGOT in Norway
Voices
Aug 20, 2025, 23:11
Anne Susanty: Sharing the Stage with Guillermo Chantada at SIOP 2024
Career Updates
Aug 20, 2025, 22:08
Devon J Shedlock Named Vice President and Head of Oncology Cell Therapy Technology at Genentech